GENE ONLINE|News &
Opinion
Blog

Ranking & Reports
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Patent Landscape Analysis of Gene Therapy
2023-02-08
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Patent Landscape Analysis of Canine Vaccines
2023-01-04
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
2026: The Promise of Synthetic Biology
2022-08-11
Korean Companies Occupying South Korea’s Diverse Biotech Landscape
2022-08-03
South Korea’s Biotech Industry:Trends, Landscape, and Clusters Overview
2022-08-01
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
9 Leading Molecular Diagnostics Companies to Watch in Taiwan
2021-11-15
1 2 3
LATEST
GHG Emissions as a ESG Metric
2023-06-07
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
2023-06-06
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
BIO 2023 Coming to Boston, with Over 60 Taiwanese Organizations to Share their Achievements
2023-06-02
Scroll to Top